You are viewing: India Theranostics Market analysis
Part of: Theranostics Market (Global)

The India Theranostics Market was valued at $29.1 Million in 2023 and projected to reach to $52.5 Million by 2028, representing a compound annual growth rate of 12.6%. India's theranostics market is positioned for sustained growth as the country strengthens its healthcare ecosystem and embraces precision medicine paradigms.

India Theranostics Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

India Theranostics Market Trends and Insights

  • This expansion reflects India's increasing adoption of precision medicine and diagnostic-therapeutic integration across healthcare systems.
  • India's growing healthcare infrastructure, rising prevalence of chronic diseases, and expanding pharmaceutical R&D capabilities are driving demand for theranostic solutions that combine diagnostic accuracy with targeted treatment delivery. The theranostics sector in India is benefiting from government initiatives promoting advanced healthcare technologies and increased investment in medical research institutions.
  • India's cost-effective manufacturing capabilities and skilled workforce position the country as an emerging hub for theranostic development and commercialization.
  • Between 2023 and 2028, India is expected to witness accelerated adoption of theranostic applications in oncology, cardiology, and infectious disease management, supported by improving regulatory frameworks and healthcare reimbursement policies..

Key Market Statistics

  • CAGR (2023-2028) 12.6% CAGR
  • Market Size, 2023 ~USD 29.1 Million
  • Forecast, 2028 ~USD 52.5 Million
  • Country India

India Theranostics Market Overview

Market Valuation & Growth :

India's theranostics market reached USD 29.1 million in 2023 and is projected to grow to USD 52.5 million by 2028, with a CAGR of 12.6%, reflecting strong adoption of integrated diagnostic-therapeutic solutions.

Healthcare Infrastructure Expansion :

India's rapidly developing healthcare infrastructure, including increased investment in diagnostic centers and hospital networks, is creating favorable conditions for theranostics adoption across urban and emerging tier-2 cities.

Precision Medicine Adoption :

Growing awareness and acceptance of precision medicine among Indian healthcare providers and patients is driving demand for theranostic solutions that combine diagnostics with targeted therapeutics.

Disease Prevalence Drivers :

Rising incidence of cancer, cardiovascular diseases, and chronic conditions in India is accelerating the need for advanced theranostic approaches that enable early detection and personalized treatment strategies.

India Theranostics Market Dynamics

  • The 12.6% CAGR through 2028 reflects increasing investments in diagnostic infrastructure, growing medical professional expertise, and rising patient demand for personalized treatment options.
  • Government initiatives supporting healthcare modernization and the expansion of diagnostic capabilities in secondary and tertiary care centers are key growth catalysts. The market will be further propelled by India's cost-effective manufacturing capabilities, which position the country as a potential hub for theranostic product development and distribution across Asia-Pacific.
  • Collaborations between Indian healthcare institutions and global biotech firms, combined with improving regulatory frameworks, will enhance market accessibility and accelerate adoption of theranostic solutions across diverse patient populations..

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • SANOFI
  • Merck KGaA
  • NOVARTIS
  • Pfizer Inc.

    Key Takeaways

    • India's theranostics market is valued at USD 29.1 million in 2023 and is forecast to reach USD 52.5 million by 2028, growing at a 12.6% CAGR.
    • India's cost-effective manufacturing and skilled pharmaceutical workforce position the country as an emerging theranostics development and commercialization hub.
    • Government healthcare initiatives and improved regulatory frameworks in India are accelerating theranostic adoption across oncology, cardiology, and infectious disease applications.
    • India's rising chronic disease burden and expanding healthcare infrastructure are driving increased demand for precision medicine and integrated diagnostic-therapeutic solutions.

    Theranostics Market Report Scope

    Report Metric Details
    Base Year 2023
    Fastest Growing Segment THERANOSTICS CENTERS (End User)
    Forecast Period 2023-2028
    Growth Rate CAGR of 15.5% from 2023 to 2028
    Largest Segment RADIOPHARMACEUTICALS (Product)
    Market Size Base Year (Billions) ~USD 2.09 (2023)
    Revenue Forecast (Billions) ~USD 4.3 (2028)
    Segments Covered Product, Type, Application, End User

    India Theranostics Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Product

    • Diagnostic Imaging
    • Ivd/Biomarker Screening
    • Radiopharmaceuticals
    • Software & Services

    By Type

    • Iodine-131
    • Lutetium-177
    • Other Radiopharmaceuticals
    • Radium-223
    • Samarium-153
    • Yttrium-90

    By Application

    • Bone Metastasis
    • Other Applications
    • Other Cancer
    • Other Cancers
    • Prostate Cancer

    By End User

    • Hospitals And Cancer Care Centers
    • Research And Academic Centers
    • Theranostics Centers

    Target Audience

    • Pharmaceutical & Biotech Companies : Need India-specific market data to evaluate theranostics commercialization opportunities, assess market entry feasibility, and develop localized product strategies for the Indian healthcare system.
    • Diagnostic & Medical Device Manufacturers : Require detailed market insights to identify growth segments, competitive positioning, and distribution channels for theranostic solutions in India's expanding diagnostic infrastructure.
    • Healthcare Investors & Private Equity : Seek comprehensive India market analysis to evaluate investment opportunities, assess portfolio company growth potential, and identify emerging theranostics players in the Indian market.
    • Hospital Networks & Healthcare Providers : Need market intelligence to understand theranostics adoption trends, patient demand patterns, and technology integration requirements for enhancing diagnostic and treatment capabilities.
    • Government & Policy Makers : Require market data to inform healthcare policy decisions, infrastructure investments, and regulatory frameworks supporting precision medicine and theranostics adoption across India.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise market valuation data for India's theranostics sector with verified CAGR of 12.6% (2023-2028), enabling accurate business planning and investment decisions in this high-growth healthcare segment.
    • Competitive Landscape Intelligence : Understand India-specific market dynamics, key players, and competitive positioning to identify partnership opportunities, market entry strategies, and differentiation approaches for theranostic solutions.
    • Regional Growth Drivers Analysis : Access detailed insights into India's healthcare infrastructure expansion, precision medicine adoption trends, and disease prevalence patterns that are fueling theranostics market growth.
    • Investment & Expansion Strategy : Leverage India-focused market forecasts and segment analysis to guide capital allocation, facility planning, and go-to-market strategies for theranostic products and services.
    • Regulatory & Operational Insights : Gain country-specific understanding of India's healthcare regulations, reimbursement landscape, and operational requirements essential for successful theranostics market penetration.

    Frequently asked questions

    What is the current size of India's theranostics market?

    India's theranostics market was valued at USD 29.1 million in 2023 and is projected to grow to USD 52.5 million by 2028.

    What is the expected growth rate for theranostics in India?

    India's theranostics market is expected to grow at a compound annual growth rate (CAGR) of 12.6% from 2023 to 2028.

    Which therapeutic areas are driving theranostics adoption in India?

    Oncology, cardiology, and infectious disease management are the primary therapeutic areas driving theranostics adoption in India.

    What factors are supporting theranostics market growth in India?

    India's growing healthcare infrastructure, rising chronic disease prevalence, government healthcare initiatives, improved regulatory frameworks, and cost-effective manufacturing capabilities are key growth drivers.

    Why is India positioned as a theranostics hub?

    India's skilled pharmaceutical workforce, cost-effective manufacturing capabilities, expanding R&D infrastructure, and government support for advanced healthcare technologies position it as an emerging theranostics development and commercialization center.

    RESEARCH METHODOLOGY

    The study involved four major activities in estimating the current size of the theranostics market. Exhaustive secondary research was done to collect information on the market, peer, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial theranostics market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as OEMs, CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the theranostics market. The primary sources from the demand side include medical CDMOs, oncologists, doctors, radiologists, technicians, and service providers. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

    A breakdown of the primary respondents is provided below:

    Theranostics Market Size, and Share

    *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note: Companies are classified into tiers based on their total revenue. As of 2021, Tier 1 = >USD 1,000 million, Tier 2 = USD 500–1,000 million, and Tier 3 = <USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Estimation Methodology

    In this report, the theranostics market’s size was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the market business were determined through various insigh ts gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.

    Segmental revenues were calculated based on the revenue mapping of major solution/service providers to calculate the global market value. This process involved the following steps:

    • Generating a list of major global players operating in the theranostics market.
    • Mapping annual revenues generated by major global players from the product segment (or nearest reported business unit/category)
    • Revenue mapping of major players to cover a major share of the global market share, as of 2022
    • Extrapolating the global value of the theranostics market industry

    Theranostics Market Size, and Share

    Data Triangulation

    After arriving at the overall market size from the market size estimation process explained above, the global theranostics market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the market was validated using top-down and bottom-up approaches.

    Market Definition

    Theranostics is a term used for diagnosis and therapy. Theranostics can be broadly defined as a combination of molecularly targeted imaging and therapy, whereas imaging helps to gain information regarding presence of targeted moleculaes on cell surface and therapy progression. Radiotheranostics involves the use of radionuclide/radiopharmaceutical that delivers targeted radiation to kill the cancerous cells and imaging modality such as positron emission tomography (PET) is used to locate the cancer.  FDA approved theranostics procedures are performed for different applications such as prostate cancer, neuroendocrine tumor, etc. These procedures are mainly performed in hospitals, cancer care centers, and  theranostics centers.

    Key Stakeholders

    • Senior Management
    • End Users
    • R&D Department
    • Finance/Procurement Department

    Objectives of the Study

    • To define, describe, and forecast the size of theranostics market based on product, application, end user, and region
    • To provide detailed information regarding the major factors influencing the growth potential of the global market (drivers, restraints, opportunities, challenges, and trends)  
    • To analyze the micro markets with respect to individual growth trends, prospects, and contributions to the global market.   
    • To analyze key growth opportunities in the global market for key stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of market segments and/or subsegments with respect to three major regions, namely, North America (US and Canada), Europe (Germany, France, the UK, and the RoE), Asia Pacific (Japan, China, India, and the RoAPAC), and Rest of the World (Latin America and Middle East and Africa).
    • To profile the key players in the market and comprehensively analyze their market shares and core competencies.
    • To track and analyze the competitive developments undertaken in the global market, such as product launches; agreements; expansions; and mergers & acquisitions.

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for the present global theranostics market report:

    Product Analysis

    • Product matrix, which gives a detailed comparison of the product portfolios of the top fifteen companies

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Geographic Analysis

    • Further breakdown of the Rest of Europe theranostics market into Italy, Spain Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal, among others
    • Further breakdown of the Rest of Asia Pacific theranostics market into Australia, South Korea, Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries

    Get the Full Theranostics Market Report

    Full forecast, segment splits, and company analysis for all Theranostics Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status